MOOV
Live / Applied — Revived — awaiting further action (as of 26 May 2025)
What this means for you
Not registered yet, but its 20 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97556947
- Mark type
- Stylized text
- Filed
- 20 Aug 2022
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Ardelle St.George
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for the delivery of molecules and compounds transdermally, through the dermal or skin layer, and orally through sublingual tablets that deliver molecules through mucosal pathways, under the tongue, via innovative medical products and therapies to treat a wide variety of ailments and health conditions, pain and inflammation pain relief biodermals, including lotions, creams and sublinguals
Owner
- REMY Biosciences, Inc., Newport Coast, CA, US
- REMY Biosciences, Inc., Newport Coast, CA, US
Prosecution history
- 06 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 May 2025 — PETITION TO REVIVE-GRANTED
- 26 May 2025 — TEAS PETITION TO REVIVE RECEIVED
- 26 May 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 May 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION
- 07 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 May 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 May 2024 — ASSIGNED TO LIE
- 18 Dec 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Sept 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED